News

Calviri Scientists Find New Class of Biomarkers for Predicting Treatment Response in Cancer Patients

by

Newly observed anti-FSP antibodies also found to predict immune-related adverse events PHOENIX, May 23, 2023 /PRNewswire/ — Scientists studying immune checkpoint inhibitor (ICI) therapies in advanced lung cancer patients have found that a new class of blood-based biomarkers— anti-frameshift peptide antibodies, or anti-FSP antibodies— could be developed into improved or orthogonal tests for predicting tumor … Read more

Applied Radiology and Guerbet Launch ‘Elucirem (Gadopiclenol) injection

by

Partnership Features New Imaging Contest for MR Imaging Professionals using Elucirem™ (Gadopiclenol) Injection, a Novel New Macrocyclic GBCA for Use in Contrast-Enhanced Magnetic Resonance Imaging (MRI) Winning Images to Be Featured on Applied Radiology Website and First Place “Image of the Year” Winner to be Announced at Annual RSNA Conference in November PRINCETON, N.J., May … Read more

ImmPACT Bio to Present at the 2023 Jefferies Healthcare Conference

by

WEST HILLS, Calif., May 23, 2023 /PRNewswire/ — ImmPACT Bio USA, Inc. (“ImmPACT BIO”), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune diseases, today announced that it will participate at the 2023 Jefferies Healthcare Conference, to be held from June 7-9, 2023, in New York, NY. … Read more

Genprex Unveils New Video Featuring Chief Medical Officer Discussing Positive Preclinical Data With NPRL2 Gene Therapy Utilizing Non-Viral ONCOPREX® Nanoparticle Delivery System

by

Chief Medical Officer Provides Overview of Preclinical Data Recently Presented at the 2023 American Association of Cancer Research (AACR) annual meeting Video Highlights Validation of the ONCOPREX® Nanoparticle Delivery System with a Second Tumor Suppressor Gene AUSTIN, Texas, May 23, 2023 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company … Read more

CG Cosmetic, the pioneer in breast augmentation, is launching the revolutionary Face PET Lift!

by

A non-invasive procedure based on anatomical studies, delivering natural-looking results without cuts or stitches. MIAMI, May 23, 2023 /PRNewswire/ — CG Cosmetic, a leading cosmetic surgery center known for its pioneering work in breast augmentation, is proud to announce the launch of a revolutionary new procedure for the face, the Face PET Lift. This unique … Read more

BD Advances Prefilled Flush Syringe with Integrated ‘Scrub-the-Hub’ Innovation

by

BD PosiFlush™ SafeScrub Streamlines Clinical Workflow for Disinfecting and Flushing IV Catheters to Help Improve Patient Care FRANKLIN LAKES, N.J., May 23, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced expanded customer availability of an all-in-one prefilled flush syringe with an integrated disinfection unit designed to … Read more

Powered by Its Industry-Leading Comprehensive Multi-Omic Database, Caris Life Sciences to Showcase Extensive Research at ASCO 2023

by

In collaboration with leading cancer centers, research results to be presented from 42 studies across more than 30 solid tumor types demonstrating Caris’ impact on precision medicine IRVING, Texas, May 23, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, today announced that … Read more

VR-Based Meditation Apps Present Opportunities

by

DUBLIN, May 23, 2023 /PRNewswire/ — The “Mindfulness Meditation Application: Global Market” report has been added to  ResearchAndMarkets.com’s offering. In this report, the market has been segmented based on service type, operating system, age group, end user, and geographic region. The report provides an overview of the global market for mindfulness meditation applications and analyzes market … Read more